RecallDepth
Class II Terminated

Janumet (sitagliptin and metformin HCl) tablets, 50 mg/500 mg, 14-count bottle, packaged as 2 bottles per carton , Sample-Not For Sale, Rx Only, Manufactured for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. Whitehouse Station, NJ 08889, USA, by Patheon Puerto Rico, Inc. Manati, Puerto Rico, 00674 Bottle (NDC 0006-0575-02), Carton (NDC 0006-0575-03)

This recall has been terminated (originally issued April 13, 2022).

Company
Merck Sharp & Dohme Corp
Recall Initiated
March 31, 2022
Posted
April 13, 2022
Recall Number
D-0746-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
3600 cartons
Firm Location
Whitehouse Station, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Presence of foreign substance: Presence of stainless steel particulates in tablets.

Distribution

Nationwide in the USA

Lot / Code Info

Lot: U015824, Exp. 09/22.

More recalls by Merck Sharp & Dohme Corp

View all recalls by this company →

Other recent Class II Drug recalls